Table 3.
Univariate and multivariate analysis of the prognostic factors contributing to recurrence free survival
| Multivariate Analysis | |||
|---|---|---|---|
| Variables | Univariate Analysis (P value) | Hazard Ratio (95%CI) |
P value |
| Surgical resection vs PRFA | 0.324 | 0.988(0.896-1.124) | 0.902 |
| Gender (male vs female) | 0.605 | ||
| Age (> 65 vs ≤ 65) | 0.392 | ||
| HBV vs non HBV | 0.399 | ||
| HCV vs non HCV | 0.022 | 0.630 (0.367-1.079) | 0.093 |
| LC vs non LC | 0.002 | 0.586 (0.334-1.027) | 0.048 |
| Albumin (g/dL) (> 3.5 vs ≤ 3.5) | 0.531 | ||
| T-Bil (mg/dL) (> 1.0 vs ≤ 1.0) | 0.703 | ||
| Platelet (×104/mm3) (> 10 vs ≤ 10) | 0.005 | 1.334 (0.889-2.001) | 0.125 |
| Prothrombin time (%) (> 80 vs ≤ 80) |
0.696 | ||
| Serum AFP (> 100 vs ≤ 100) | 0.857 | ||
| PIVKAII (> 100 vs ≤ 100) | 0.807 | ||
| Tumor size (cm) (> 2 vs ≤ 2) | 0.389 | ||
PRFA, percutaneous radiofrequency thermal ablation; HBV, hepatitis B virus; HCV, hepatitis C virus; LC, liver cirrhosis; T-Bil, total bilirubin; CI, confidence interval; AFP, alpha-fetoprotein; PIVKAII, protein induced vitamin K absence or antagonist II